Testing a new medicine in hospitalized pneumonia patients needing oxygen
Part of Infections, Lungs & breathing clinical trials.
This Phase 2 trial tests an investigational medicine (given in increasing doses) for hospitalized people with pneumonia who need supplemental oxygen. It aims to see if the medicine is safe and potentially helps the pneumonia process in the early hospital period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and are hospitalized with pneumonia that is less than 48 hours in the hospital
- You need extra oxygen because of pneumonia (or you were admitted for another reason and then developed pneumonia)
- Chest imaging (like X-ray/CT) shows new or worsening lung infection (infiltrate, consolidation, or cavitation)
- You must have at least 1 sign (for example: fast breathing, fever, abnormal white blood cells, age 70+, or confusion without another cause) and at least 1 symptom (for example: new/worse cough, trouble breathing, purulent sputum, or abnormal lung sounds)
- If you can become pregnant, you must use effective birth control
- You should not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests NOA-001, a treatment given to people with ARDS (a serious lung condition) who are already on a breathing machine. It looks at whether the treatment can improve outcomes in ARDS caused by either non-COVID illnesses or COVID-19.
This trial tests whether adding an experimental drug called agenT-797 to standard pneumonia treatment helps patients in the ICU who have severe pneumonia and serious difficulty breathing (acute hypoxemic respiratory failure). The drug is designed to help the immune system fight severe infection.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This early (Phase 1) study tests AVM0703 in adults who are very sick with lung failure caused by COVID-19 or influenza (flu). It aims to see if the treatment is safe and potentially helpful when standard rescue breathing treatments are not enough.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.